Cargando…
Development of Antithrombogenic ECM-Based Nanocomposite Heart Valve Leaflets
[Image: see text] Thrombogenicity, which is commonly encountered in artificial heart valves after replacement surgeries, causes valvular failure. Even life-long anticoagulant drug use may not be sufficient to prevent thrombogenicity. In this study, it was aimed to develop a heart valve construct wit...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2022
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382671/ https://www.ncbi.nlm.nih.gov/pubmed/35839464 http://dx.doi.org/10.1021/acsabm.2c00423 |